• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Congenital Heart Disease: An Overview

January 22, 2016 By Dr. Jeremy Feldman

Dr. Tabitha Moe
Dr. Tabitha Moe

What is Congenital Heart Disease?

As we are developing from a single egg fertilized by a single sperm, cells divide and begin to develop into the different tissues of our adult bodies.  This is a very complex process that is like a kind of perfectly choreographed ballet.  A special cluster of cells slowly differentiates into the cardiovascular system.  Cells that become the heart must rotate, turn and twist to form a normal heart.

Occasionally this process of normal development does not occur perfectly.  This results in abnormal connections in the heart and after birth we call these defects congenital heart disease.

Did You Know that Nearly 1 out of 100 Births Today are Affected by some form of Congenital Heart Disease?

Some kinds of congenital heart disease are at increased risk for developing pulmonary hypertension over their lifetime.  The risk of developing pulmonary hypertension exists even if you have had surgery or a procedure to repair the original heart defect.  The most common congenital heart problem in childhood that may eventually lead to pulmonary hypertension is a hole between the two bottom pumping chambers of the heart called a ventricular septal defect (VSD).  Sometimes this defect may close on its own, other times it may require surgery to be closed.  Some patients with small ventricular septal defects may be monitored by specialists in adult congenital heart disease.

The most common congenital heart problem in adulthood that may lead to pulmonary hypertension is a hole between the two top chambers of the heart or an atrial septal defect (ASD). This defect if very small may also be called a patent foramen ovale or a PFO.  When the defect is very small it may be something that can be monitored closely by a cardiologist who is familiar with the management of congenital heart disease. In order to treat this defect you may be able to undergo a simple, minimally invasive, catheter-based procedure to have the defect closed, in more complicated cases surgery may be required.

There are different types of atrial septal defects.  The most common type is the one that can be closed typically with the previously mentioned catheter-based technique.   The other types of atrial septal defect can not be closed with a catheter-based technique and require surgery by an experienced congenital heart surgeon.  These types include holes between the two top chambers which are too large or too high or low on the wall to be safely closed with a catheter-based device.

Often, if a procedure or surgery is performed when the patient is an infant or a small child the risks of developing pulmonary hypertension over the patient’s lifetime are not communicated to the patient.  The cardiologists and the surgeon rely on the parents and grandparents to remember and tell the child what needs to be done over their lifetime.  Many times this message is lost or forgotten as the caregivers age or change and as the child grows into adulthood.

Complex Congenital Heart Disease

There are many more complicated forms of congenital heart disease that are also associated with PAH.  These include but are not limited to: Tetralogy of Fallot (TOF), Patent Ductus Arteriosus (PDA), Truncus Arteriosus, and Anomalous Pulmonary Venous Return.  We will discuss some of these in dedicated posts.

If you or someone you love had a heart procedure or a heart surgery as a child to have a hole in the heart closed, you should seek out your community’s adult congenital cardiology specialist for an evaluation.  This evaluation may include such tests as a walking test to evaluate your ability to exercise, a transthoracic echocardiogram or an ultrasound using soundwaves to take pictures of your heart and a visit with an adult congenital cardiology specialist.

Filed Under: Pulmonary Hypertension Diagnosis

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

Update on PAH Treatments

Updates on Opsumit and Adempas; New Treatments for PAH

By Dr. Jeremy Feldman

In October 2013 the FDA approved Opsumit (Macitnentan) and Adempas (Riociguat) to treat pulmonary arterial

congenital heart disease atrial septal defect

FAQ’s: Oral Treatments, Care Centers & Hole in Heart

By Dr. Jeremy Feldman

Your Questions Answered Is there an oral treatment that can replace continuously infused therapy

good news in pah

 

Disclaimer

Recent Blog Posts

  • Sotatercept Coming Soon January 10, 2023
  • Why Abortion Matters to PAH Patients May 3, 2022
  • Aerovate and Inhaled Imatinib February 13, 2022

Categories

Archives